Last 12 months
Inside the activity.
2 purchase rows · 31 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 5 |
| Dec 2025 | 0 | 2 |
| Jan 2026 | 0 | 16 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 4 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 2 | 2 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 02, 2026 Filed Jan 6, 2026 21:30 UTC |
Powl Brian T.Chief Commercial Officer
|
GrantOption to purchase common stock · Derivative | 100,000 | $0.00 Strike: $10.34 | $0.00 |
DisclosureSEC source: 0001193125-26-004564 · ownership.xml · derivative · entry 2 Powl Brian T. · CIK 0001934232 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2036-01-01 F2 · derivative.exercise_date: This option vests in 48 equal monthly installments commencing on the grant date. Read SEC document |
| January 02, 2026 Filed Jan 6, 2026 21:30 UTC |
Powl Brian T.Chief Commercial Officer
|
GrantCommon Stock | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-004564 · ownership.xml · nonDerivative · entry 1 Powl Brian T. · CIK 0001934232 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 189,689 F1 · shares: Grant of Restricted Stock Units (RSUs). The RSUs vest in four equal annual installments on 1/26/27, 1/26/28, 1/26/29 and 1/26/30. Read SEC document |
| December 18, 2025 Filed Dec 19, 2025 16:30 UTC |
Burrows FrancisChief Scientific Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 35,000 | $0.00 Strike: $4.80 | $0.00 |
DisclosureSEC source: 0001193125-25-326948 · ownership.xml · derivative · entry 3 Burrows Francis · CIK 0002051119 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common stock · 35,000 shares Expires 2026-01-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Cashless exercise and sale of a portion of a stock option to cover estimated payroll tax liability. F4 · derivative.exercise_date: This option is fully vested. Read SEC document |
| December 18, 2025 Filed Dec 19, 2025 16:30 UTC |
Burrows FrancisChief Scientific Officer
|
SaleCommon Stock | 23,726 | $9.78 | $231,931.14 |
DisclosureSEC source: 0001193125-25-326948 · ownership.xml · nonDerivative · entry 2 Burrows Francis · CIK 0002051119 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,735 F3 · price: This transaction was executed in multiple trades at prices ranging from $9.77 to $9.82. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| December 18, 2025 Filed Dec 19, 2025 16:30 UTC |
Burrows FrancisChief Scientific Officer
|
Exercise / conversionCommon Stock | 35,000 | $4.80 | $168,000.00 |
DisclosureSEC source: 0001193125-25-326948 · ownership.xml · nonDerivative · entry 1 Burrows Francis · CIK 0002051119 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57,461 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Cashless exercise and sale of a portion of a stock option to cover estimated payroll tax liability. F2 · balance_after: Includes 857 shares acquired on May 17, 2025 and 899 shares acquired on November 17, 2025 pursuant to the Issuer's Employee Stock Purchase Plan. Read SEC document |
| December 09, 2025 Filed Dec 10, 2025 21:05 UTC |
Hasnain FaheemDirector
|
SaleCommon Stock | 10,000 | $10.98 | $109,764.00 |
DisclosureSEC source: 0001193125-25-314154 · ownership.xml · nonDerivative · entry 2 Hasnain Faheem · CIK 0001352620 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,983 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 8, 2025. F2 · price: This transaction was executed in multiple trades at prices ranging from $10.60 to $11.53. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| December 09, 2025 Filed Dec 10, 2025 21:05 UTC |
Hasnain FaheemDirector
|
Exercise / conversionCommon Stock | 10,000 | $3.12 | $31,200.00 |
DisclosureSEC source: 0001193125-25-314154 · ownership.xml · nonDerivative · entry 1 Hasnain Faheem · CIK 0001352620 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,983 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 8, 2025. Read SEC document |
| November 14, 2025 Filed Nov 15, 2025 01:00 UTC |
Leoni MollieChief Medical Officer
|
SaleCommon Stock | 15,485 | $11.18 | $173,074.30 |
DisclosureSEC source: 0001193125-25-283563 · ownership.xml · nonDerivative · entry 2 Leoni Mollie · CIK 0002051106 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 225,454 F1 · kind: Sell-to-cover for taxes associated with the vesting of 1/6th of the underlying shares of performance-based restricted stock units ("PSUs") granted to the Reporting Person on May 31, 2023 and January 2, 2025. Each PSU represents the contingent right to receive one share of the Issuer's common stock based on the achievement of each of three specified development milestones, and the one-year anniversary of each milestone achievement, subject to the Reporting Person's continuous service on each corresponding vesting date. The performance criteria for one specified development milestone was determined to be met on November 13, 2025, resulting in the vesting of 1/6th of the underlying shares. Read SEC document |
| November 14, 2025 Filed Nov 15, 2025 01:00 UTC |
Bair Teresa BrophyChief Legal Officer
|
SaleCommon Stock | 8,804 | $11.18 | $98,401.43 |
DisclosureSEC source: 0001193125-25-283568 · ownership.xml · nonDerivative · entry 2 Bair Teresa Brophy · CIK 0001813058 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 188,139 F1 · kind: Sell-to-cover for taxes associated with the vesting of 1/6th of the underlying shares of performance-based restricted stock units ("PSUs") granted to the Reporting Person on May 31, 2023. Each PSU represents the contingent right to receive one share of the Issuer's common stock based on the achievement of each of three specified development milestones, and the one-year anniversary of each milestone achievement, subject to the Reporting Person's continuous service on each corresponding vesting date. The performance criteria for one specified development milestone was determined to be met on November 13, 2025, resulting in the vesting of 1/6th of the underlying shares. Read SEC document |
| November 14, 2025 Filed Nov 15, 2025 01:00 UTC |
Powl Brian T.Chief Commercial Officer
|
SaleCommon Stock | 8,887 | $11.18 | $99,329.11 |
DisclosureSEC source: 0001193125-25-283564 · ownership.xml · nonDerivative · entry 2 Powl Brian T. · CIK 0001934232 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 139,689 F2 · kind: Sell-to cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 11/13/25. Read SEC document |
| November 14, 2025 Filed Nov 15, 2025 01:00 UTC |
FORD KATHLEENChief Operating Officer
|
SaleCommon Stock | 6,902 | $11.18 | $77,142.96 |
DisclosureSEC source: 0001193125-25-283560 · ownership.xml · nonDerivative · entry 2 FORD KATHLEEN · CIK 0001785406 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 105,373 F1 · kind: Sell-to-cover for taxes associated with the vesting of 1/6th of the underlying shares of performance-based restricted stock units ("PSUs") granted to the Reporting Person on May 31, 2023. Each PSU represents the contingent right to receive one share of the Issuer's common stock based on the achievement of each of three specified development milestones, and the one-year anniversary of each milestone achievement, subject to the Reporting Person's continuous service on each corresponding vesting date. The performance criteria for one specified development milestone was determined to be met on November 13, 2025, resulting in the vesting of 1/6th of the underlying shares. Read SEC document |
| November 14, 2025 Filed Nov 15, 2025 01:00 UTC |
DOYLE THOMAS JAMESSVP, Finance & Accounting
|
SaleCommon Stock | 4,539 | $11.18 | $50,731.95 |
DisclosureSEC source: 0001193125-25-283562 · ownership.xml · nonDerivative · entry 2 DOYLE THOMAS JAMES · CIK 0001910331 · SVP, Finance & Accounting 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 130,257 F1 · kind: Sell-to-cover for taxes associated with the vesting of 1/6th of the underlying shares of performance-based restricted stock units ("PSUs") granted to the Reporting Person on May 31, 2023. Each PSU represents the contingent right to receive one share of the Issuer's common stock based on the achievement of each of three specified development milestones, and the one-year anniversary of each milestone achievement, subject to the Reporting Person's continuous service on each corresponding vesting date. The performance criteria for one specified development milestone was determined to be met on November 13, 2025, resulting in the vesting of 1/6th of the underlying shares. Read SEC document |
| November 13, 2025 Filed Nov 15, 2025 01:00 UTC |
Leoni MollieChief Medical Officer
|
GrantCommon Stock | 82,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-25-283563 · ownership.xml · nonDerivative · entry 1 Leoni Mollie · CIK 0002051106 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 240,939 Read SEC document |
| November 13, 2025 Filed Nov 15, 2025 01:00 UTC |
Bair Teresa BrophyChief Legal Officer
|
GrantCommon Stock | 48,900 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-25-283568 · ownership.xml · nonDerivative · entry 1 Bair Teresa Brophy · CIK 0001813058 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 196,943 Read SEC document |
| November 13, 2025 Filed Nov 15, 2025 01:00 UTC |
WILSON TROY EDWARDDirector · President and CEO
|
GrantCommon Stock | 182,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-25-283565 · ownership.xml · nonDerivative · entry 1 WILSON TROY EDWARD · CIK 0001589597 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 429,353 F1 · kind: Represents 1/3rd of the underlying shares of performance-based restricted stock units ("PSUs") granted to the Reporting Person on May 31, 2023. Each PSU represents the contingent right to receive one share of the Issuer's common stock based on the achievement of each of three specified development milestones, and the one-year anniversary of each milestone achievement, subject to the Reporting Person's continuous service on each corresponding vesting date. The performance criteria for one specified development milestone was determined to be met on November 13, 2025, resulting in the vesting of 1/6th of the underlying shares. Read SEC document |
| November 13, 2025 Filed Nov 15, 2025 01:00 UTC |
Powl Brian T.Chief Commercial Officer
|
GrantCommon Stock | 48,900 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-25-283564 · ownership.xml · nonDerivative · entry 1 Powl Brian T. · CIK 0001934232 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 148,576 F1 · shares: Grant of Restricted Stock Units (RSUs). The RSUs vest 50% immediately and 50% on 11/13/26. Read SEC document |
| November 13, 2025 Filed Nov 15, 2025 01:00 UTC |
FORD KATHLEENChief Operating Officer
|
GrantCommon Stock | 48,900 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-25-283560 · ownership.xml · nonDerivative · entry 1 FORD KATHLEEN · CIK 0001785406 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 112,275 Read SEC document |
| November 13, 2025 Filed Nov 15, 2025 01:00 UTC |
DOYLE THOMAS JAMESSVP, Finance & Accounting
|
GrantCommon Stock | 24,967 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-25-283562 · ownership.xml · nonDerivative · entry 1 DOYLE THOMAS JAMES · CIK 0001910331 · SVP, Finance & Accounting 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 134,796 Read SEC document |
| September 29, 2025 Filed Sep 29, 2025 23:30 UTC |
Leoni MollieChief Medical Officer
|
SaleCommon Stock | 12,314 | $8.94 | $110,114.25 |
DisclosureSEC source: 0001193125-25-223664 · ownership.xml · nonDerivative · entry 2 Leoni Mollie · CIK 0002051106 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 158,439 F1 · kind: Sell-to-cover for taxes associated with the vesting of 1/6th of the underlying shares of performance-based restricted stock units ("PSUs") granted to the Reporting Person on May 31, 2023 and January 2, 2025. Each PSU represents the contingent right to receive one share of the Issuer's common stock based on the achievement of each of three specified development milestones, and the one-year anniversary of each milestone achievement, subject to the Reporting Person's continuous service on each corresponding vesting date. The performance criteria for one specified development milestone was determined to be met on September 27, 2025, resulting in the vesting of 1/6th of the underlying shares. Read SEC document |
| September 29, 2025 Filed Sep 29, 2025 23:30 UTC |
Bair Teresa BrophyChief Legal Officer
|
SaleCommon Stock | 8,805 | $8.94 | $78,736.07 |
DisclosureSEC source: 0001193125-25-223666 · ownership.xml · nonDerivative · entry 2 Bair Teresa Brophy · CIK 0001813058 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 148,043 F1 · kind: Sell-to-cover for taxes associated with the vesting of 1/6th of the underlying shares of performance-based restricted stock units ("PSUs") granted to the Reporting Person on May 31, 2023. Each PSU represents the contingent right to receive one share of the Issuer's common stock based on the achievement of each of three specified development milestones, and the one-year anniversary of each milestone achievement, subject to the Reporting Person's continuous service on each corresponding vesting date. The performance criteria for one specified development milestone was determined to be met on September 27, 2025, resulting in the vesting of 1/6th of the underlying shares. Read SEC document |
| September 29, 2025 Filed Sep 29, 2025 23:30 UTC |
Powl Brian T.Chief Commercial Officer
|
SaleCommon Stock | 8,891 | $8.94 | $79,505.10 |
DisclosureSEC source: 0001193125-25-223667 · ownership.xml · nonDerivative · entry 2 Powl Brian T. · CIK 0001934232 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 99,676 F1 · kind: Sell-to cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 9/27/25. Read SEC document |
| September 29, 2025 Filed Sep 29, 2025 23:30 UTC |
FORD KATHLEENChief Operating Officer
|
SaleCommon Stock | 6,892 | $8.94 | $61,629.64 |
DisclosureSEC source: 0001193125-25-223665 · ownership.xml · nonDerivative · entry 2 FORD KATHLEEN · CIK 0001785406 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 63,375 F1 · kind: Sell-to-cover for taxes associated with the vesting of 1/6th of the underlying shares of performance-based restricted stock units ("PSUs") granted to the Reporting Person on May 31, 2023. Each PSU represents the contingent right to receive one share of the Issuer's common stock based on the achievement of each of three specified development milestones, and the one-year anniversary of each milestone achievement, subject to the Reporting Person's continuous service on each corresponding vesting date. The performance criteria for one specified development milestone was determined to be met on September 27, 2025, resulting in the vesting of 1/6th of the underlying shares. Read SEC document |
| September 29, 2025 Filed Sep 29, 2025 23:30 UTC |
WILSON TROY EDWARDDirector · President and CEO
|
SaleCommon Stock | 36,615 | $8.94 | $327,418.65 |
DisclosureSEC source: 0001193125-25-223663 · ownership.xml · nonDerivative · entry 2 WILSON TROY EDWARD · CIK 0001589597 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 246,853 F1 · kind: Sell-to-cover for taxes associated with the vesting of 1/6th of the underlying shares of performance-based restricted stock units ("PSUs") granted to the Reporting Person on May 31, 2023. Each PSU represents the contingent right to receive one share of the Issuer's common stock based on the achievement of each of three specified development milestones, and the one-year anniversary of each milestone achievement, subject to the Reporting Person's continuous service on each corresponding vesting date. The performance criteria for one specified development milestone was determined to be met on September 27, 2025, resulting in the vesting of 1/6th of the underlying shares. Read SEC document |
| September 29, 2025 Filed Sep 29, 2025 23:30 UTC |
DOYLE THOMAS JAMESSVP, Finance & Accounting
|
SaleCommon Stock | 4,541 | $8.94 | $40,606.53 |
DisclosureSEC source: 0001193125-25-223662 · ownership.xml · nonDerivative · entry 2 DOYLE THOMAS JAMES · CIK 0001910331 · SVP, Finance & Accounting 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 109,829 F2 · kind: Sell-to-cover for taxes associated with the vesting of 1/6th of the underlying shares of performance-based restricted stock units ("PSUs") granted to the Reporting Person on May 31, 2023. Each PSU represents the contingent right to receive one share of the Issuer's common stock based on the achievement of each of three specified development milestones, and the one-year anniversary of each milestone achievement, subject to the Reporting Person's continuous service on each corresponding vesting date. The performance criteria for one specified development milestone was determined to be met on September 27, 2025, resulting in the vesting of 1/6th of the underlying shares. Read SEC document |
| September 27, 2025 Filed Sep 29, 2025 23:30 UTC |
Leoni MollieChief Medical Officer
|
GrantCommon Stock | 82,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-25-223664 · ownership.xml · nonDerivative · entry 1 Leoni Mollie · CIK 0002051106 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 170,753 Read SEC document |
| September 27, 2025 Filed Sep 29, 2025 23:30 UTC |
Bair Teresa BrophyChief Legal Officer
|
GrantCommon Stock | 48,900 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-25-223666 · ownership.xml · nonDerivative · entry 1 Bair Teresa Brophy · CIK 0001813058 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 156,848 Read SEC document |
| September 27, 2025 Filed Sep 29, 2025 23:30 UTC |
Powl Brian T.Chief Commercial Officer
|
GrantCommon Stock | 48,900 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-25-223667 · ownership.xml · nonDerivative · entry 1 Powl Brian T. · CIK 0001934232 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 108,567 Read SEC document |
| September 27, 2025 Filed Sep 29, 2025 23:30 UTC |
FORD KATHLEENChief Operating Officer
|
GrantCommon Stock | 48,900 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-25-223665 · ownership.xml · nonDerivative · entry 1 FORD KATHLEEN · CIK 0001785406 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 70,267 Read SEC document |
| September 27, 2025 Filed Sep 29, 2025 23:30 UTC |
WILSON TROY EDWARDDirector · President and CEO
|
GrantCommon Stock | 182,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-25-223663 · ownership.xml · nonDerivative · entry 1 WILSON TROY EDWARD · CIK 0001589597 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 283,468 Read SEC document |
| September 27, 2025 Filed Sep 29, 2025 23:30 UTC |
DOYLE THOMAS JAMESSVP, Finance & Accounting
|
GrantCommon Stock | 24,966 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-25-223662 · ownership.xml · nonDerivative · entry 1 DOYLE THOMAS JAMES · CIK 0001910331 · SVP, Finance & Accounting 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 114,370 F1 · balance_after: Includes 1,211 shares acquired on May 17, 2025 pursuant to the Issuer's Employee Stock Purchase Plan. Read SEC document |
| September 08, 2025 Filed Sep 9, 2025 20:28 UTC |
WILSON TROY EDWARDDirector · President & CEO
|
PurchaseCommon Stock | 50,000 | $8.20 | $410,145.00 |
DisclosureSEC source: 0001415889-25-023974 · form4-09092025_080937.xml · nonDerivative · entry 1 WILSON TROY EDWARD · CIK 0001589597 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,968 F1 · price: This transaction was executed in multiple trades at prices ranging from $8.135 to $8.24. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakesto provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| August 13, 2025 Filed Aug 14, 2025 20:05 UTC |
WILSON TROY EDWARDDirector · President and CEO
|
PurchaseCommon Stock | 13,494 | $6.64 | $89,623.10 |
DisclosureSEC source: 0000950170-25-108844 · ownership.xml · nonDerivative · entry 2 WILSON TROY EDWARD · CIK 0001589597 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,968 F3 · price: This transaction was executed in multiple trades at prices ranging from $6.485 to $6.735. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| August 12, 2025 Filed Aug 14, 2025 20:05 UTC |
WILSON TROY EDWARDDirector · President and CEO
|
PurchaseCommon Stock | 36,506 | $5.85 | $213,578.35 |
DisclosureSEC source: 0000950170-25-108844 · ownership.xml · nonDerivative · entry 1 WILSON TROY EDWARD · CIK 0001589597 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,474 F1 · price: This transaction was executed in multiple trades at prices ranging from $5.56 to $5.995. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F2 · balance_after: Includes 409 shares acquired on May 17, 2024 pursuant to the Issuer's Employee Stock Purchase Plan. Read SEC document |
| June 05, 2025 Filed Jun 6, 2025 20:05 UTC |
Parks Diane L.Director
|
GrantOption to purchase common stock · Derivative | 28,500 | $0.00 Strike: $6.57 | $0.00 |
DisclosureSEC source: 0000950170-25-083040 · ownership.xml · derivative · entry 1 Parks Diane L. · CIK 0001781026 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,500 Underlying: Common Stock · 28,500 shares Expires 2035-06-04 F1 · derivative.exercise_date: This option vests in full on the one year anniversary of the date of grant. Read SEC document |
| June 05, 2025 Filed Jun 6, 2025 20:05 UTC |
Collins Helen LouiseDirector
|
GrantOption to purchase common stock · Derivative | 28,500 | $0.00 Strike: $6.57 | $0.00 |
DisclosureSEC source: 0000950170-25-083041 · ownership.xml · derivative · entry 1 Collins Helen Louise · CIK 0001701247 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,500 Underlying: Common Stock · 28,500 shares Expires 2035-06-04 F1 · derivative.exercise_date: This option vests in full on the one year anniversary of the date of grant. Read SEC document |
| June 05, 2025 Filed Jun 6, 2025 20:05 UTC |
SCHAFER CAROLDirector
|
GrantOption to purchase common stock · Derivative | 28,500 | $0.00 Strike: $6.57 | $0.00 |
DisclosureSEC source: 0000950170-25-083038 · ownership.xml · derivative · entry 1 SCHAFER CAROL · CIK 0001272181 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,500 Underlying: Common Stock · 28,500 shares Expires 2035-06-04 F1 · derivative.exercise_date: This option vests in full on the one year anniversary of the date of grant. Read SEC document |
| June 05, 2025 Filed Jun 6, 2025 20:05 UTC |
VASCONCELLES MICHAELDirector
|
GrantOption to purchase common stock · Derivative | 28,500 | $0.00 Strike: $6.57 | $0.00 |
DisclosureSEC source: 0000950170-25-083037 · ownership.xml · derivative · entry 1 VASCONCELLES MICHAEL · CIK 0001734755 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,500 Underlying: Common Stock · 28,500 shares Expires 2035-06-04 F1 · derivative.exercise_date: This option vests in full on the one year anniversary of the date of grant. Read SEC document |
| June 05, 2025 Filed Jun 6, 2025 20:05 UTC |
Hasnain FaheemDirector
|
GrantOption to purchase common stock · Derivative | 28,500 | $0.00 Strike: $6.57 | $0.00 |
DisclosureSEC source: 0000950170-25-083039 · ownership.xml · derivative · entry 1 Hasnain Faheem · CIK 0001352620 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,500 Underlying: Common Stock · 28,500 shares Expires 2035-06-04 F1 · derivative.exercise_date: This option vests in full on the one year anniversary of the date of grant. Read SEC document |
| June 05, 2025 Filed Jun 6, 2025 20:05 UTC |
Malley ThomasDirector
|
GrantOption to purchase common stock · Derivative | 28,500 | $0.00 Strike: $6.57 | $0.00 |
DisclosureSEC source: 0000950170-25-083036 · ownership.xml · derivative · entry 1 Malley Thomas · CIK 0001403322 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,500 Underlying: Common Stock · 28,500 shares Expires 2035-06-04 F1 · derivative.exercise_date: This option vests in full on the one year anniversary of the date of grant. Read SEC document |
| June 05, 2025 Filed Jun 6, 2025 20:05 UTC |
Szela Mary TDirector
|
GrantOption to purchase common stock · Derivative | 28,500 | $0.00 Strike: $6.57 | $0.00 |
DisclosureSEC source: 0000950170-25-083035 · ownership.xml · derivative · entry 1 Szela Mary T · CIK 0001410289 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,500 Underlying: Common Stock · 28,500 shares Expires 2035-06-04 F1 · derivative.exercise_date: This option vests in full on the one year anniversary of the date of grant. Read SEC document |
| May 19, 2025 Filed May 19, 2025 22:30 UTC |
Bair Teresa BrophyChief Legal Officer
|
SaleCommon Stock | 1,559 | $5.96 | $9,291.64 |
DisclosureSEC source: 0000950170-25-074660 · ownership.xml · nonDerivative · entry 1 Bair Teresa Brophy · CIK 0001813058 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 107,948 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 31, 2024. F2 · shares: 1,559 shares were acquired on May 17, 2025 pursuant to the Issuer's Employee Stock Purchase Plan. Read SEC document |
| May 19, 2025 Filed May 19, 2025 22:30 UTC |
FORD KATHLEENChief Operating Officer
|
SaleCommon Stock | 1,558 | $6.28 | $9,777.38 |
DisclosureSEC source: 0000950170-25-074659 · ownership.xml · nonDerivative · entry 1 FORD KATHLEEN · CIK 0001785406 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 21,367 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 10, 2024. F2 · shares: 1,558 shares were acquired on May 17, 2025 pursuant to the Issuer's Employee Stock Purchase Plan. F3 · price: This transaction was executed in multiple trades at prices ranging from $6.27 to $6.28. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 21, 2025 Filed Mar 24, 2025 20:33 UTC |
Hasnain FaheemDirector
|
SaleCommon Stock | 22,682 | $8.00 | $181,456.00 |
DisclosureSEC source: 0000950170-25-043903 · ownership.xml · nonDerivative · entry 2 Hasnain Faheem · CIK 0001352620 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,983 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 20, 2024. F2 · price: This transaction was executed in multiple trades at prices ranging from $8.00 to $8.03. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 21, 2025 Filed Mar 24, 2025 20:33 UTC |
Hasnain FaheemDirector
|
Exercise / conversionCommon Stock | 22,682 | $6.32 | $143,350.24 |
DisclosureSEC source: 0000950170-25-043903 · ownership.xml · nonDerivative · entry 1 Hasnain Faheem · CIK 0001352620 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,665 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 20, 2024. Read SEC document |
| January 28, 2025 Filed Jan 29, 2025 01:39 UTC |
Leoni MollieChief Medical Officer
|
SaleCommon Stock | 541 | $7.87 | $4,258.70 |
DisclosureSEC source: 0000950170-25-010121 · ownership.xml · nonDerivative · entry 4 Leoni Mollie · CIK 0002051106 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 88,253 F4 · acquired: Sell-to cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 1/26/21. Read SEC document |
| January 28, 2025 Filed Jan 29, 2025 01:39 UTC |
Leoni MollieChief Medical Officer
|
SaleCommon Stock | 816 | $7.87 | $6,423.47 |
DisclosureSEC source: 0000950170-25-010121 · ownership.xml · nonDerivative · entry 3 Leoni Mollie · CIK 0002051106 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 88,794 F3 · acquired: Sell-to cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 2/16/23. Read SEC document |
| January 28, 2025 Filed Jan 29, 2025 01:39 UTC |
Leoni MollieChief Medical Officer
|
SaleCommon Stock | 1,353 | $7.87 | $10,650.68 |
DisclosureSEC source: 0000950170-25-010121 · ownership.xml · nonDerivative · entry 2 Leoni Mollie · CIK 0002051106 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 89,610 F2 · acquired: Sell-to cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 1/26/22. Read SEC document |
| January 28, 2025 Filed Jan 29, 2025 01:39 UTC |
Leoni MollieChief Medical Officer
|
SaleCommon Stock | 2,253 | $7.87 | $17,735.39 |
DisclosureSEC source: 0000950170-25-010121 · ownership.xml · nonDerivative · entry 1 Leoni Mollie · CIK 0002051106 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 90,963 F1 · acquired: Sell-to cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 1/2/24. Read SEC document |
| January 28, 2025 Filed Jan 28, 2025 20:38 UTC |
Burrows FrancisChief Scientific Officer
|
SaleCommon Stock | 1,320 | $7.87 | $10,390.91 |
DisclosureSEC source: 0000950170-25-010117 · ownership.xml · nonDerivative · entry 2 Burrows Francis · CIK 0002051119 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,705 F2 · acquired: Sell-to cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 1/26/22. Read SEC document |
| January 28, 2025 Filed Jan 28, 2025 20:38 UTC |
Burrows FrancisChief Scientific Officer
|
SaleCommon Stock | 846 | $7.87 | $6,659.63 |
DisclosureSEC source: 0000950170-25-010117 · ownership.xml · nonDerivative · entry 1 Burrows Francis · CIK 0002051119 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,025 F1 · acquired: Sell-to cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 1/26/21. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.